Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases
Victoria Furer, Christien Rondaan, Nancy Agmon‐Levin, Sander van Assen, Marc Bijl, Meliha C Kapetanovic, Annette de Thurah, Ulf Müeller-Ladner, Daphna Paran, Karen Schreiber, Klaus Warnatz, Nico Wulffraat, Ori Elkayam
Abstract
In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients.